⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGN UPCOMING DEADLINE: SueWallSt Alerts Regeneron Pharmaceuticals, Inc. Stockholders of Securities Class Action - Contact the Firm
globenewswire.com
REGN
Kalohexis Appoints Garry Menzel, Ph.D., to Board of Directors
prnewswire.com
BTAI
REGN
STOK
TCRX
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
REGN
Levi & Korsinsky Urges Regeneron Pharmaceuticals, Inc. (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
REGN EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
globenewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
REGN